Testing an AI helper for eye care in the community
Part of Eyes & vision clinical trials.
This study tests how well a computer program called a large language model can help with eye care in real community settings. It may help doctors and patients better manage eye conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can be any age, male or female
- You have an eye condition that needs a specialist, or can be treated at your local clinic, or your eyes are healthy
- You are willing to take part and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new, intelligent way to screen for and diagnose eye diseases using a mobile device. It may help catch eye problems early, especially in people who have trouble getting to a doctor.
This trial tests a new artificial intelligence system that helps eye doctors make decisions. You may qualify if you are having a routine eye exam and can get clear images of both eyes.
This trial tests how artificial intelligence can help doctors make better decisions about eye diseases. It may be a good fit if you have an eye condition and can share your medical records and images.
This trial uses artificial intelligence to help doctors make better decisions about eye disease. It analyzes your medical records and images to see how AI can improve care and track disease.
This trial uses artificial intelligence to analyze eye images and help diagnose and prioritize eye conditions. It could help find the right treatment faster.
This trial tests an artificial intelligence (AI) tool that uses eye images to help doctors diagnose breathing or lung-related conditions. If you have a lung/breathing problem and can do both eye and lung checkups, it may support faster or more accurate diagnosis.
Hear when a new Ophthalmic Diseases (Specific Types Not Restricted) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.